Refinement of plasma fetal hemoglobin (hbf) measurements, as related to whole blood hbf, in cancer patients

Journal of Tumor Marker Oncology

Volumn 14, Issue 2, 1999, Pages 115-124

  Wolk, Moshe ^a,b,c   Newland, Adrian C ^a,b,c   De La Salle, Barbara ^a,b,c   Peleg, Michèle ^a,b,c   Brufman, George ^a,b,c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c NONE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 3142588258     PISSN: 08863849     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Jacobson GK, Jacobson M: Immunohistochemical demonstration of hemoglobin F (HbF) in testicular germ cell tumors. Oncodevep Biol Med 1983;4:45-51
2. Albrechtsen R, Wever U, Wimberely PP: Immunohistochemical demonstration of a hitherto undescribed localization of hemoglobin A and F in endodermal cells of normal human yolk sac and endodermal sinus tumor. Acta Path Microbiol Scand A 1980;88:175-178.
3. Jacobson GK, Jacobson M: Alphafetoprotein (AFP) and human chorionic (HCG) in testicular germ cell tumor. A prospective immunohistological study. Acta Pathol Microbiol Scand Sect A 1983; 91: 165176.
4. Jacobson GK: Tumor markers in testicular germ cell tumor related to the stage of the disease at the time of diagnosis. Oncodevep Biol 1986;4:3944.
5. Neville AM: Tumor markers and their clinical value. Tumor Biol 1986;7:8390.
6. Rowland RG: Serum markers in testicular germ-cell neoplasms. Hematol Oncol Clin North Amer 1988;2;485-489
7. Go JH, Bae JY, Kim TS: Intracranial immature teratoma with syncytiotrophoblastis and tumor marker positive intestinal lining cells. Yonsei Med J 1995:36:534-537.
8. Stevens MJ, Norman AR, Dearnaley DP, Norwich A: Prognostic significance of early serumtumor marker half-life in metastatic testicular teratoma. J Clin Oncol 1995; 13:87-92.
9. Salzman KL, Rojiani AM, Buatti J, Quisling RG, Marcus RB, Maria BL, Mickle JP, Kedar A: Primary intracranial germ cell tumors: Clinicopathogenic review of 32 cases. Pediat Pathol Labor Med 1997;7:713-727.
10. Grady RW, Ross JH, Kay R: Prepubertal population. The J Urol 1997;158:1191-1192.
11. Forni M, Meyer PR, Levy NB, Lukes RJ, Taylor CR: An immunohistochemical study of hemoglobin A, hemoglobin F, Muramidase, and transferin in erythroid hyperplasia and neoplasia. Amer J Pathol 1983;80:145151.
12. Wölk M, Kieselstein M: Graded hemagglutination inhibition for quantification of human fetal hemoglobin. Clin Chem 1983;29:1372-1375.
13. Wölk M, Kieselstein M, Brufman G: Evaluation of fetal hemoglobin in various malignancies with reference to the patients' age. Tumor Biol 1988; 9:95-100.
14. Wölk M, Kieselstein M, Ben-dor CG, Brufman G: Fetal Hemoglobin screening in whole blood and in plasma of cancer patients. Tumor Biol 1991;12:45-51.
15. Avrameas S, Taudou B, Chuilon S: Glutaraldehyde, cyanuric chloride and tetrazotized o-dianiside as coupling reagents in the passive hemagglutination test. Immumochemistry 1969;6:67-76.
16. Vanzetti G, Valente D: A sensitive method for the determination of hemoglobin in plasma. Clin Chem Acta 1965:11:442-446.
17. Pipkin FB: Medical statistics made easy. Churchill Livingston, Edinburgh, 1984.
18. Fox H: Advances in the histopathology of ovarian tumors; in Newman CE, Ford CHJ, Jordan JA (ed): Advances in the biosciences. Oxford, Pergamon, 1979, vol 26, pp 9-26.
19. Zalel Y. Piura B, Elchalal U, Czemobilskiy B, Antebi S, Dagani R: Diagnosis and management of malignant germ cell ovarian tumors in young females. Int J Gynaecol Obstet 1996:55:1-10.
20. Bosl GJ, Motzer RJ: Testicular germ cell cancer. New Engl J Med 1997:337:242-253.
21. Hirschowitz L, Ansari A, Cahill DJ, Bamford DS, Love S: Central neurocytoma arising within a mature cystic teratoma of the ovary. Int J Gynecol Pathol 1997;16:176-179.
22. Underwood JCE, Dangerfield VJM: Immunohistochemical identification of adult and fetal haemopoiesis in the spleen in lymphoma, leukemia and myeloproliferative diseases. J Pathol 1981;134:71-80.
23. Rochant H, Dreyfus B, Bouguerra M, Ton-Hat H: Refractory animias, preleukimic conditions and fetal erythropoiesis. Blood 1972;39:721726.
24. Newman DR, Pierre RV, Linman JW: Studies on the diagnostic significance of hemoglobin F levels. Mayo Clin Prod 973:48:199-202.
25. Garnick AB, Ferry JA: Case records of Massachusetts general hospital. New Engt J Med 1997;337:1904-1911.
26. Rautonen J, Sûmes MA: Initial blood fetal hemoglobin concentration is elevated and is associated with prognosis in children with acute lymphoid or myeloid leukemia. Blut 1990;61:17-20.
27. Wakul S, Furusato'M, Itoh T, Sasaki H, Akiyama A, Kinoshita I, Asano K, Tokuda T, Aizawa S, Ushigome S: Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastasis: A morphometric study. J Pathol 1992;168;257-262.
28. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J: Tumor angiogenesis correlation with metastasis in invasive prostate carcinoma. Amer J Pathol 1993; 143:401-409.
29. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allerd EN, Moore DH, Meli S, Gasparini G: Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma.
30. Kaelin WG, Mayer RJ: Hématologie complication of cancer and cancer therapy; in Moossa RA, Schimpff SC, Robson MC (ed): Comperhensive textbook of oncology. ed2, Baltimore Williams & Williams, 1986, pp1751.